These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51 related articles for article (PubMed ID: 20663703)
1. [Analysis of the duration of and reasons for changing the first combination of antiretroviral therapy]. Martín MT; Rovira M; Massanes M; del Cacho E; Carcelero E; Tuset M; Codina C; Miro JM; Gatell JM; Ribas J Farm Hosp; 2010; 34(5):224-30. PubMed ID: 20663703 [TBL] [Abstract][Full Text] [Related]
3. History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change. Reekie J; Mocroft A; Ledergerber B; Beniowski M; Clotet B; van Lunzen J; Chiesi A; Pradier C; Machala L; Lundgren JD; HIV Med; 2010 Aug; 11(7):469-78. PubMed ID: 20201975 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of a 24 month follow-up of HIV patients without change in their primary antiretroviral therapy]. Marcos Sánchez F; Marcos Sánchez F; Albo Castaño I; Arbol Linde F; Viana Alonso A An Med Interna; 2003 Nov; 20(11):599. PubMed ID: 14624662 [No Abstract] [Full Text] [Related]
6. Efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) in Thai HIV-infected patients. Kiertiburanakul S; Khongnorasat S; Rattanasiri S; Sungkanuparph S J Med Assoc Thai; 2007 Feb; 90(2):237-43. PubMed ID: 17375626 [TBL] [Abstract][Full Text] [Related]
7. Clinical audit: virological and immunological response to combination antiretroviral therapy in HIV patients at a Sydney sexual health clinic. Hsu DC; Quin JW Intern Med J; 2010 Apr; 40(4):265-74. PubMed ID: 19460050 [TBL] [Abstract][Full Text] [Related]
8. Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years. Cuzin L; Delpierre C; Gerard S; Massip P; Marchou B Clin Infect Dis; 2007 Sep; 45(5):654-7. PubMed ID: 17683004 [TBL] [Abstract][Full Text] [Related]
9. Stopping antiretroviral therapy: role for therapeutic drug monitoring. Tommasi C; Nicastri E; Corpolongo A; Ivanovic J; Notari S; Ascenzi P; Andreoni M; Narciso P AIDS; 2008 Jan; 22(2):315-6. PubMed ID: 18097237 [No Abstract] [Full Text] [Related]
10. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
11. Differences in rates of diarrhea in patients with human immunodeficiency virus receiving lopinavir-ritonavir or nelfinavir. Guest JL; Ruffin C; Tschampa JM; DeSilva KE; Rimland D Pharmacotherapy; 2004 Jun; 24(6):727-35. PubMed ID: 15222662 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of antiretroviral drug resistance in antiretroviral-naive individuals. James CW; Moffett LE; Szabo S J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):193-5. PubMed ID: 19414829 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of a pill-swallowing training intervention to improve antiretroviral medication adherence in pediatric patients with HIV/AIDS. Garvie PA; Lensing S; Rai SN Pediatrics; 2007 Apr; 119(4):e893-9. PubMed ID: 17353298 [TBL] [Abstract][Full Text] [Related]
14. [HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy]. Jambroes M; Weverling GJ; Reiss P; Danner SA; Jurriaans S; ten Veen JH; van der Ende ME; Schutten M; Schneider MM; Schuurman R; Mulder JW; Kroes AC; Lange JM; de Wolf F; Ned Tijdschr Geneeskd; 2001 Aug; 145(33):1591-7. PubMed ID: 11534377 [TBL] [Abstract][Full Text] [Related]
15. Genotypic resistance mutations in treatment-naïve and treatment-experienced patients under widespread use of antiretroviral drugs in Thailand: implications for further epidemiologic surveillance. Sukasem C; Churdboonchart V; Sirisidthi K; Riengrojpitak S; Chasombat S; Watitpun C; Piroj W; Tiensuwan M; Chantratita W Jpn J Infect Dis; 2007 Sep; 60(5):284-9. PubMed ID: 17881868 [TBL] [Abstract][Full Text] [Related]
16. Starting or changing therapy - a prospective study exploring antiretroviral decision-making. Fehr JS; Nicca D; Sendi P; Wolf E; Wagels T; Kiss A; Bregenzer T; Vernazza P; Jäger H; Spirig R; Battegay M; Infection; 2005 Aug; 33(4):249-56. PubMed ID: 16091895 [TBL] [Abstract][Full Text] [Related]
17. Contraindicated antiretroviral drug combinations. Macher A; Thomas D; Paul SM N J Med; 2003 Sep; 100(9 Suppl):41-3; quiz 73-4. PubMed ID: 14556602 [TBL] [Abstract][Full Text] [Related]